SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-029985
Filing Date
2011-05-18
Accepted
2011-05-18 16:54:40
Documents
5
Period of Report
2011-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-8037_38k.htm 8-K 28687
2 EX-1.1 a11-8037_3ex1d1.htm EX-1.1 233350
3 EX-5.1 a11-8037_3ex5d1.htm EX-5.1 11254
4 EX-99.1 a11-8037_3ex99d1.htm EX-99.1 14103
5 GRAPHIC g80373moi001.jpg GRAPHIC 3745
  Complete submission text file 0001104659-11-029985.txt   293996
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 11855424
SIC: 2835 In Vitro & In Vivo Diagnostic Substances